All News Oncologix Tech, Inc.

Equities

OCLG

US68230M2098

Market Closed - OTC Markets Other stock markets 14:30:03 28/05/2024 BST			5-day change	1st Jan Change
0.0002 ^USD	-.--%		-.--%	-92.00%

2022	DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction.	CI
2016	Oncologix Tech, Inc. Announces Management Changes	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

DNAGO and Oncologix Tech, Inc. Announce Agreement for Business Combination to Create Publicly Listed Company Focused on Providing clinical genetic testing on all 20,000+ genes encompassing 7,000+ rare genetic diseases at affordable price	02/05/22	GL
DNAGO and Oncologix Tech, Inc. Announce Agreement for Business Combination to Create Publicly Listed Company Focused on Providing clinical genetic testing on all 20,000+ genes encompassing 7,000+ rare genetic diseases at affordable price	02/05/22	AQ
DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction.	01/05/22	CI
Oncologix Tech, Inc. Announces Management Changes	02/12/16	CI
Oncologix Tech, Inc. announced that it expects to receive $10 million in funding from Diversified Innovative Marketing Enterprises Limited	30/08/16	CI
Oncologix Tech, Inc. Announces Board Changes	24/06/16	CI
Oncologix Tech, Inc. Appoints Nikole Jessie as Director of Marketing and Public Relations	29/07/15	CI
Oncologix Tech Inc. Reports Revenue Results Third Quarter and Nine Months Ending May 31, 2015	21/07/15	CI
Oncologix Tech Eyes Acquisitions	21/07/15	CI
Oncologix Tech, Inc. Announces Earnings Results for the Second Quarter and Revenue Results for the Six Months Ended February 28, 2015; Provides Earnings Guidance for the Third Quarter and Full Year of Fiscal 2015	14/04/15	CI
Oncologix Seeks Acquisitions	14/04/15	CI
Oncologix Tech, Inc. Reports Earnings Results for the First Quarter Ending November 30, 2014; Provides Earnings Guidance for Second Quarter of 2015	16/01/15	CI
OCLG Mulls Acquisitions	30/12/14	CI
Oncologix Tech Mulls Acquisitions	07/10/14	CI
Oncologix Tech, Inc. acquired Esteemcare Inc. from Madhu Mathew Mammen and Imad Siddiqui for $0.5 million.	02/10/14	CI
Oncologix Tech, Inc. Announces Revenue Results for the Second Quarter and Half Year Ended February 28, 2014	21/04/14	CI
Oncologix Tech Inc. Closes $4,000,000 Revolving Credit Facility from Senior Lender	08/01/14	CI
Oncologix Tech, Inc. announced that it has received $0.04 million in funding.	07/08/13	CI
Oncologix Tech, Inc. acquired Angels of Mercy, Inc. from Clifford Haw and Jennifer Hebert for $0.65 million.	05/08/13	CI
Oncologix Tech, Inc. announced that it has received $0.1 million in funding	25/07/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Oncologix Tech, Inc.

Equities

OCLG

US68230M2098

All News

Filters